When did savella come out?

When was Savella first approved?

Savella (milnacipran hydrochloride) was approved by the U.S. Food and Drug Administration (FDA) on December 20, 2006 [1].

What is Savella used for?

Savella is prescribed to treat fibromyalgia, a condition characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues [1].

When does Savella's patent protection expire?

Information regarding the specific patent expiration dates for Savella is proprietary. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can be consulted for detailed data [2].

What are the common side effects of Savella?

Common side effects reported by patients taking Savella include nausea, headache, dizziness, insomnia, constipation, vomiting, and dry mouth [1].

What are the risks associated with Savella?

Savella carries a boxed warning regarding the risk of suicidal thoughts and behaviors, particularly in children, adolescents, and young adults, similar to other antidepressant medications [1]. Other potential serious risks include serotonin syndrome and changes in blood pressure or heart rate [1].

Can Savella be used with other medications?

Patients should inform their doctor about all medications they are taking, as Savella can interact with certain drugs, including other antidepressants, MAO inhibitors, and NSAIDs [1].